Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-08-12
1999-11-23
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
059901349
ABSTRACT:
Oral dosage form of droperidol are provided and a method for treating migraine using such oral formulations. The dosage forms include tablets, capsules, powders, effervescent formulations and syrups.
REFERENCES:
patent: 5118508 (1992-06-01), Kikuchi et al.
patent: 5288497 (1994-02-01), Stanley et al.
patent: 5310561 (1994-05-01), Jao et al.
Wang, et al. Droperidol Treatment of Status Migrainosus and Refractory Migraine, Headache. Jun., 1997, pp. 377-382.
Wang, et al., Droperidol Treatment of Acute Refractory Migraine and Status Migrainosus, Headache, Apr., 1996, p. 280.
John F. Rothrock, MD., Treatment of Acute Migraine with Intravenous Droperidol, Headache, Apr. 1997, pp. 256-257.
Nageotte et al., American Journal of Obstetrics and Gynecology, 174/6 (1801-6) (abstract), 1996.
Kymer et al., Journal of Clinical anesthesia, 7/1 (35-9) (abstract), Feb. 1995.
Spivack Phyllis G.
Taylor Pharmaceuticals
LandOfFree
Oral droperidol compositions and method for treating migraine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral droperidol compositions and method for treating migraine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral droperidol compositions and method for treating migraine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222315